TY - JOUR
T1 - Impact of COVID-19 pandemic on rates of congenital heart disease procedures among children
T2 - prospective cohort analyses of 26 270 procedures in 17 860 children using CVD-COVID-UK consortium record linkage data
AU - CVD-COVID-UK/COVID-IMPACT Consortium
AU - Karthikeyan Suseeladevi, Arun
AU - Denholm, Rachel
AU - Babu-Narayan, Sonya V
AU - Sinha, Shubhra
AU - Stoica, Serban
AU - Dong, Tim
AU - Angelini, Gianni D
AU - Sudlow, Cathie L M
AU - Walker, Venexia
AU - Brown, Kate
AU - Caputo, Massimo
AU - Lawlor, Debbie A
N1 - © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.
Data Availability Statement
Data may be obtained from a third party and are not publicly available. The data used in this study are available in NHS England’s Secure Data Environment (SDE) service for England, but as restrictions apply they are not publicly available (https://digital.nhs.uk/services/secure-data-environment- service). The CVD-COVIDUK/COVID-IMPACT programme, led by the BHF Data Science Centre (https://bhfdatasciencecentre.org/), received approval to access data in NHS England’s SDE service for England from the Independent Group Advising on the Release of Data (IGARD) (https://digital.nhs.uk/about-nhs-digital/ corporate-information-anddocuments/independent-group-advising-on-the-release- of-data) via an application made inthe Data Access Request Service (DARS) Online system (ref. DARS- NIC- 381078- Y9C5K)(https://digital.nhs.uk/services/data-access- request-service-dars/dars-products-andservices). The CVD- COVID- UK/COVID- IMPACT Approvals & Oversight Board (https://bhfdatasciencecentre.org/areas/cvd- covid-uk-covid-impact/) subsequently granted approval to this project to access the data within NHS England’s SDE service for England. The deidentified data used in this study were made available to accredited researchers only. Those wishing to gain access to the data should contact [email protected] in the first instance.
PY - 2025/3/25
Y1 - 2025/3/25
N2 - BACKGROUND: The COVID-19 pandemic necessitated major reallocation of healthcare services. Our aim was to assess the impact on paediatric congenital heart disease (CHD) procedures during different pandemic periods compared with the prepandemic period, to inform appropriate responses to future major health services disruptions.METHODS AND RESULTS: We analysed 26 270 procedures from 17 860 children between 1 January 2018 and 31 March 2022 in England, linking them to primary/secondary care data. The study period included prepandemic and pandemic phases, with the latter including three restriction periods and corresponding relaxation periods. We compared procedure characteristics and outcomes between each pandemic period and the prepandemic period. There was a reduction in all procedures across all pandemic periods, with the largest reductions during the first, most severe restriction period (23 March 2020 to 23 June 2020), and the relaxation period following second restrictions (3 December 2020 to 4 January 2021) coinciding with winter pressures. During the first restrictions, median procedures per week dropped by 51 compared with the prepandemic period (80 vs 131 per week, p=4.98×10-08). Elective procedures drove these reductions, falling from 96 to 44 per week (p=1.89×10-06), while urgent (28 vs 27 per week, p=0.649) and life-saving/emergency procedures (7 vs 6 per week, p=0.198) remained unchanged. Cardiac surgery rates increased, and catheter-based procedure rates reduced during the pandemic. Procedures for children under 1 year were prioritised, especially during the first four pandemic periods. No evidence was found for differences in postprocedure complications (age-adjusted OR 1.1 (95% CI 0.9, 1.4)) or postprocedure mortality (age and case mix adjusted OR 0.9 (95% CI 0.6, 1.3)).CONCLUSIONS: Prioritisation of urgent, emergency and life-saving procedures during the pandemic, particularly in infants, did not impact paediatric CHD postprocedure complications or mortality. This information is valuable for future major health services disruptions, though longer-term follow-up of the effects of delaying elective surgery is needed.
AB - BACKGROUND: The COVID-19 pandemic necessitated major reallocation of healthcare services. Our aim was to assess the impact on paediatric congenital heart disease (CHD) procedures during different pandemic periods compared with the prepandemic period, to inform appropriate responses to future major health services disruptions.METHODS AND RESULTS: We analysed 26 270 procedures from 17 860 children between 1 January 2018 and 31 March 2022 in England, linking them to primary/secondary care data. The study period included prepandemic and pandemic phases, with the latter including three restriction periods and corresponding relaxation periods. We compared procedure characteristics and outcomes between each pandemic period and the prepandemic period. There was a reduction in all procedures across all pandemic periods, with the largest reductions during the first, most severe restriction period (23 March 2020 to 23 June 2020), and the relaxation period following second restrictions (3 December 2020 to 4 January 2021) coinciding with winter pressures. During the first restrictions, median procedures per week dropped by 51 compared with the prepandemic period (80 vs 131 per week, p=4.98×10-08). Elective procedures drove these reductions, falling from 96 to 44 per week (p=1.89×10-06), while urgent (28 vs 27 per week, p=0.649) and life-saving/emergency procedures (7 vs 6 per week, p=0.198) remained unchanged. Cardiac surgery rates increased, and catheter-based procedure rates reduced during the pandemic. Procedures for children under 1 year were prioritised, especially during the first four pandemic periods. No evidence was found for differences in postprocedure complications (age-adjusted OR 1.1 (95% CI 0.9, 1.4)) or postprocedure mortality (age and case mix adjusted OR 0.9 (95% CI 0.6, 1.3)).CONCLUSIONS: Prioritisation of urgent, emergency and life-saving procedures during the pandemic, particularly in infants, did not impact paediatric CHD postprocedure complications or mortality. This information is valuable for future major health services disruptions, though longer-term follow-up of the effects of delaying elective surgery is needed.
KW - Humans
KW - COVID-19/epidemiology
KW - Heart Defects, Congenital/surgery
KW - Infant
KW - Male
KW - Child, Preschool
KW - Prospective Studies
KW - Child
KW - Female
KW - Infant, Newborn
KW - Cardiac Surgical Procedures/statistics & numerical data
KW - SARS-CoV-2
KW - England/epidemiology
KW - Pandemics
KW - Adolescent
U2 - 10.1136/openhrt-2024-003054
DO - 10.1136/openhrt-2024-003054
M3 - Article
C2 - 40132895
SN - 2053-3624
VL - 12
JO - Open heart
JF - Open heart
IS - 1
M1 - e003054
ER -